It appears that you are viewing this site with something other than a standards compliant graphical browser. This site will work and look better in a browser that supports web standards, but it is accessible to any browser or Internet device.
Basic Design   |  Skip to content  |  Site Map   |  Search   -   Print page
South Australian Government logo. Link to Government Ministers' web site. Department of Health logo. Link to web site.
Module Border Module Border
  What's New 

Module Border Module Border
  Chapter 20 Breech presentation 

Disclaimer | Literature review | Definition | Contributing factors | Antenatal examination | External cephalic version (ECV) | Contraindications to ECV | Guideline for ECV | Salbutamol tocolysis | Breech delivery management | Elective caesarean management  | Vaginal breech birth | References | Last reviewed
 
Show as single page

Salbutamol tocolysis

>  Continuous CTG during procedure

Preparation

>  Exclude a history of maternal cardiac disease or arrhythmia / untreated thyrotoxicosis

Dosage and administration

>  Obstetric salbutamol:  5 mL ampoule 5 mg / 5 mL    

>  Using a 1 mL syringe, draw up 0.25 mL (250 micrograms) of salbutamol

>  Add to a 10 mL syringe and make up to 10 mL with sodium chloride 0.9 % (25 micrograms per mL)

>  Give intravenous salbutamol slowly in 50 microgram boluses up to 250 micrograms in total (often 100 micrograms will be sufficient)

>  Ensure monitoring of maternal pulse whilst bolus doses are administered 

>  Stop IV administration if maternal pulse > 140

Side effects

>  Fetal and maternal tachycardia, maternal hypotension, ventricular ectopics, supra-ventricular tachycardia, ventricular fibrillation, pulmonary oedema, hypoxia – secondary to increased oxygen demands + / - fluid shift in lungs, hyperglycaemia 

top


Guideline for ECV | Page 9 of 14 | Breech delivery management